A phase I study to compare the steady-state pharmacokinetics of estradiol following application to the abdomen of an Estradiol Metered-Dose Transdermal Spray (MDTS) and Estraderm 50 patches in healthy postmenopausal women, as hormone replacement therapy.
Completed
- Conditions
- Hormone replacement therapy for post-menopausal womenReproductive Health and Childbirth - Menstruation and menopause
- Registration Number
- ACTRN12605000521628
- Lead Sponsor
- FemPharm Pty Ltd and/or Acrux DDS Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 18
Inclusion Criteria
Healthy post-menopausal women
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method